An observational study suggests that adding coronary artery calcium results to traditional risk models yields synergistic value and the promise of a precision medicine approach.Read More
Heart patients are embracing a variety of smartphone apps, which are proving easy to use, affordable and available without a prescription. Yet serious issues of data transmission and storage, confidentiality and reimbursement remain unresolved.
When young hearts start to fail, optimal management involves forestalling transplant when possible — increasingly, with LVADs — and being ready to transplant when needed.
Valve-in-valve TAVR can be a lifesaving treatment for patients with severely degenerated, surgically placed aortic prostheses, who are at extreme risk for open surgical replacement.
When an ischemic peripheral lesion cannot be crossed using the typical antegrade approach, tibiopedal retrograde access often raises the chance of success and allows angioplasty to proceed.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
By combining laparoscopy and endoscopy, the Digestive Disease Institute’s new Developmental Endoscopy Group is now able to provide new minimally invasive options to patients for motility disorders and GI cancers.
Considering family history is critical for the prevention of future heart disease in pediatric patients. Children at risk benefit from evaluation and treatment in multidisciplinary clinics.
Carotid ultrasound is a pragmatic way to assess cardiac risk in patients with psoriatic arthritis and identify those who would benefit from early interventions
Five new technologies — subcutaneous ICDs, contact force ablation catheters, leadless pacemakers, a vagal nerve stimulator and a left atrial appendage occlusion device — are making EP procedures safer and more effective.
Cleveland Clinic Florida has hired Cedric Sheffield, MD, as Surgical Director of its new, UNOS-approved adult heart transplant program.
Congenital bicuspid aortic valve repair carries a low risk of death, stroke and re operation, and prevents the need for lifelong anti-coagulation required for a prosthetic valve.